(MORTEMUS): a retrospective study. Lancet Neurol 2013;12(10):966–77.
Epilepsia 2023;64(4):937–50. https://doi.org/10.1111/epi.17517 [Epub 2023
https://doi.org/10.1016/S1474-4422(13)70214-X [Epub 2013 Sep 4 PMID:
Feb3PMID:36681896].
24012372].
[35] EngelgeerA,vanWestrhenenA,ThijsRD,EversSMAA.Aneconomicevaluation
[14] Sveinsson O, Andersson T, Mattsson P, Carlsson S, Tomson T. Clinical risk
oftheNightWatchforchildrenwithrefractoryepilepsy:insightintothecost-
factors in SUDEP: a nationwide population-based case-control study.
effectiveness and cost-utility. Seizure 2022;101:156–61. https://doi.org/
Neurology. 2020;94(4):e419–29. https://doi.org/10.1212/